
ESG, SRI, Oncology
From uncertainty to growth: why invest in healthcare?
As we enter the month of October, investors are faced with an obvious question: is the time right for new investments in the oncology sector? Pasquale Sansone, Senior Biotechnology Analyst, shares his analysis and convictions.